Philippe Raffy

Philippe Raffy has a diverse and extensive work experience spanning several industries. In their current role as the Chief Technology Officer at Clairity, Inc. since 2022, they oversee the company's technology strategy and initiatives. Prior to this, they served as the Vice President of Engineering at TeraRecon, Inc. from 2021 to 2022.

From 2018 to 2021, Philippe worked at Change Healthcare as the Executive Director of Artificial Intelligence. In this role, they led the creation and development of an AI Research & Development organization focused on developing AI solutions for the Radiology and Cardiology markets.

Before joining Change Healthcare, Philippe worked as a Sole Proprietor at Medical Imaging and Medical Device Consulting from 2017 to 2018. During this time, they provided consultancy services to medical device and healthcare IT startups, specializing in machine learning, data science, clinical research, and software product development.

From 2016 to 2017, Philippe served as the Vice President of Data Sciences and Clinical Development at Nucleus Health / StatRad, where they played a key role in developing and productizing cloud-based radiology software using machine learning technologies.

Prior to that, Philippe held the position of Chief Technology Officer (CTO) at VIDA Diagnostics, Inc. from 2012 to 2016. In this role, they significantly contributed to the growth and success of the company, securing funding, developing partnerships with major lung device and pharmaceutical companies, and expanding the company's technology portfolio. Philippe also managed the company's office in Minnesota and led various activities related to intellectual property, scientific design trials, and product development.

Earlier in their career, Philippe worked at Vital Images, Inc. / Toshiba Medical Systems as the Director of Research and Innovation and the Director of Clinical Development from 2007 to 2011. Philippe managed research teams, scientific collaborations, and engineering integration efforts with Toshiba Medical Systems.

Philippe also served as the Principal Investigator at R2 Technology / Hologic from 2002 to 2006, overseeing the development of Computer Aided Detection (CAD) algorithms for chest Computed Tomography releases. Before that, Philippe worked at Neomagic Corporation as a Member of Technical Staff and at Identive Corporation as a Senior Software Engineer.

Overall, Philippe Raffy's work experience showcases their expertise in various areas such as technology leadership, artificial intelligence, medical imaging, data science, and software product development.

Philippe Raffy has a strong educational background in electrical engineering. Philippe completed their PhD in Electrical Engineering from Université Côte d'Azur from 1995 to 1997. Following their PhD, they pursued a Post Doctorate degree in Electrical Engineering at Stanford University from 1998 to 2000.

In addition to their formal education, Philippe Raffy has also obtained several certifications related to artificial intelligence (AI) and machine learning. These certifications include "AI for Medicine Specialization" from Coursera (obtained in November 2022), "Introduction to Machine Learning in Production" from Coursera (obtained in December 2021), and "Deep Learning Specialization" from Coursera (obtained in April 2018). Philippe has also completed various other courses and obtained certificates in topics such as data analysis, programming, and data science through online platforms like Coursera and LinkedIn.

Based on the provided information, it can be concluded that Philippe Raffy has a strong academic background in electrical engineering and has continuously updated their skills in AI and machine learning through certifications and online courses.